ARWRARROWHEAD PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of ARROWHEAD PHARMACEUTICALS, INC. against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARWREsta | $8.1B#1 | — | 17.4x#3 | 9.8x#1 | 23258.2%#1 | 99.7%#1 | 11.9%#1 | -0.4%#1 | — | — | 42.6%#2 | — |
| TWST | $7.6B#3 | — | 17.0x#2 | 20.1x#2 | 20.3%#3 | 62.8%#2 | -36.2%#2 | -17.4%#2 | -41.4%#1 | — | 282.4%#1 | — |
| VKTX | $3.3B#4 | — | 5.6x#1 | — | — | -227.1%#4 | — | -61.1%#3 | — | — | — | — |
| CYTK | $7.8B#2 | — | — | 88.3x#3 | 376.6%#2 | -33.2%#3 | -695.4%#3 | — | — | — | -5.8%#3 | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-06.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice